MENU
+Compare
ACTU
Stock ticker: NASDAQ
AS OF
Sep 26, 04:59 PM (EDT)
Price
$6.72
Change
+$0.07 (+1.05%)
Capitalization
154.57M

ACTU Actuate Therapeutics Inc Forecast, Technical & Fundamental Analysis

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3)... Show more

ACTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ACTU with price predictions
Sep 25, 2025

ACTU sees its Stochastic Oscillator recovers from oversold territory

On September 23, 2025, the Stochastic Oscillator for ACTU moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 10 instances where the indicator left the oversold zone. In of the 10 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACTU advanced for three days, in of 57 cases, the price rose further within the following month. The odds of a continued upward trend are .

ACTU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 46 cases where ACTU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ACTU as a result. In of 24 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ACTU turned negative on September 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at .

ACTU moved below its 50-day moving average on September 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACTU crossed bearishly below the 50-day moving average on September 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACTU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACTU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ACTU's P/B Ratio (2000.000) is very high in comparison to the industry average of (19.714). P/E Ratio (0.000) is within average values for comparable stocks, (54.201). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.145). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (346.197).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACTU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ACTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACTU is expected to report earnings to fall 40.00% to -18 cents per share on December 03

Actuate Therapeutics Inc ACTU Stock Earnings Reports
Q3'25
Est.
$-0.18
Q2'25
Missed
by $0.11
The last earnings report on September 03 showed earnings per share of -30 cents, missing the estimate of -18 cents. With 23.16K shares outstanding, the current market capitalization sits at 154.57M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPNGF10.930.73
+7.16%
XPeng Inc.
SHANF0.56N/A
N/A
Shandong Molomg Petroleum Machinery Co., Ltd.
VMXXF0.10N/A
-0.20%
VALHALLA METALS INC.
SIGCY10.40-0.46
-4.24%
SIG GROUP AG
BLGO0.16-0.02
-13.01%
BioLargo, Inc.

ACTU and Stocks

Correlation & Price change

A.I.dvisor tells us that ACTU and SYRE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACTU and SYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACTU
1D Price
Change %
ACTU100%
-5.27%
SYRE - ACTU
30%
Poorly correlated
-8.18%
ERAS - ACTU
29%
Poorly correlated
-5.24%
ADPT - ACTU
28%
Poorly correlated
+2.42%
IDYA - ACTU
27%
Poorly correlated
+0.08%
IBRX - ACTU
26%
Poorly correlated
-1.60%
More